Biopharma M&A Volume, Value Bounced Back Significantly In Q4

 
• By Joseph Haas

Acquisition activity in the biopharmaceutical sector saw a strong uptick in deal value and an exponential increase in total deal value during the fourth quarter, according to data from Evaluate.

M&A activity picked up noticeably in Q4 after a downturn in Q3

More from Deals

More from Business